Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial transpeptidases are enzymes crucial for the synthesis of peptidoglycan, a major structural component of bacterial cell walls. They catalyze the cross-linking of peptide chains attached to peptidoglycan monomers. Beta-lactam antibiotics target these enzymes, but bacteria can develop resistance through the production of beta-lactamases. Clavulanic acid is a beta-lactamase inhibitor that restores the efficacy of beta-lactam antibiotics.
Beta-lactam antibiotics acylate the active site serine irreversibly, blocking enzyme function. Clavulanic acid inhibits beta-lactamases, protecting beta-lactam antibiotics from degradation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Transpeptidase (PBP).